首页> 外文期刊>Stem Cells >Graft‐Versus‐Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell‐Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations
【24h】

Graft‐Versus‐Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell‐Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations

机译:人骨髓间充质/干细胞衍生细胞内囊泡的移植物与宿主病改善是与幼稚T细胞群的外周保存相关的

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract A substantial proportion of patients with acute graft‐versus‐host disease (aGVHD) respond to cell therapy with culture‐expanded human bone marrow mesenchymal stromal/stem cells (BM‐MSCs). However, the mechanisms by which these cells can ameliorate aGVHD‐associated complications remain to be clarified. We show here that BM‐MSC‐derived extracellular vesicles (EVs) recapitulated the therapeutic effects of BM‐MSCs against aGVHD. Systemic infusion of human BM‐MSC‐derived EVs prolonged the survival of mice with aGVHD and reduced the pathologic damage in multiple GVHD‐targeted organs. In EV‐treated GVHD mice, CD4+ and CD8+ T cells were suppressed. Importantly, the ratio of CD62L‐CD44+ to CD62L?+?CD44‐ T cells was decreased, suggesting that BM‐MSC‐derived EVs suppressed the functional differentiation of T cells from a naive to an effector phenotype. BM‐MSC‐derived EVs also preserved CD4?+?CD25?+?Foxp3+ regulatory T cell populations. In a culture of CD3/CD28‐stimulated human peripheral blood mononuclear cells with BM‐MSC‐derived EVs, CD3+ T cell activation was suppressed. However, these cells were not suppressed in cultures with EVs derived from normal human dermal fibroblasts (NHDFs). NHDF‐derived EVs did not ameliorate the clinical or pathological characteristics of aGVHD in mice, suggesting an immunoregulatory function unique to BM‐MSC‐derived EVs. Microarray analysis of microRNAs in BM‐MSC‐derived EVs versus NHDF‐derived EVs showed upregulation of miR‐125a‐3p and downregulation of cell proliferative processes, as identified by Gene Ontology enrichment analysis. Collectively, our findings provide the first evidence that amelioration of aGVHD by therapeutic infusion of BM‐MSC‐derived EVs is associated with the preservation of circulating naive T cells, possibly due to the unique microRNA profiles of BM‐MSC‐derived EVs. S tem C ells 2018;36:434–445
机译:摘要急性接枝与宿主疾病(AGVHD)患者的大量比例响应培养膨胀的人骨髓间充质/干细胞(BM-MSC)的细胞疗法。然而,仍然澄清这些细胞可以改善agvhd相关并发症的机制。我们在这里展示BM-MSC衍生的细胞外囊泡(EVS)覆盖了BM-MSCs对AGVHD的治疗效果。全身输注人BM-MSC衍生的EVS延长了与AGVHD的小鼠的存活率,并降低了多种GVHD靶向器官中的病理损伤。在EV处理的GVHD小鼠中,抑制了CD4 +和CD8 + T细胞。重要的是,降低了CD62L-CD44 +至CD62L?+ + CD44-T细胞的比例,表明BM-MSC衍生的EV抑制了T细胞与效应表型的纯度的功能分化。 BM-MSC衍生的EVS也保存了CD4?+?CD25?+?Foxp3 +调节T细胞群体。在具有BM-MSC衍生EV的CD3 / CD28刺激的人外周血单核细胞的培养中,抑制了CD3 + T细胞活化。然而,这些细胞在培养物中没有抑制来自衍生自正常人皮肤成纤维细胞(NHDFS)的EV。 NHDF衍生的EV尚未改善小鼠AGVHD的临床或病理特征,表明BM-MSC衍生EV的免疫调节功能。 MICRANS在BM-MSC衍生的EV中的微阵列分析与NHDF衍生的EV,显示出MIR-125A-3P的上调和细胞增殖过程的下调,通过基因本体富集分析鉴定。集体,我们的研究结果提供了第一种证据证明,通过对BM-MSC衍生的EV的治疗输液改善AGVHD与循环幼稚T细胞的保存有关,可能是由于BM-MSC衍生的EV的独特的微小RNA型材。 STEM C ells 2018; 36:434-445

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号